Article

Reply to: Comment on: “Premedication prior to PEG-asparaginase is cost effective in pediatric patients with acute lymphoblastic leukemia”

Pediatric Blood and Cancer
DOI: 10.1002/pbc.29694
0Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Cite

CITATION STYLE

APA

McCormick, M., Friehling, E., & Smith, K. (2022, November 1). Reply to: Comment on: “Premedication prior to PEG-asparaginase is cost effective in pediatric patients with acute lymphoblastic leukemia.” Pediatric Blood and Cancer. John Wiley and Sons Inc. https://doi.org/10.1002/pbc.29694

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free